158 related articles for article (PubMed ID: 37217694)
1. Prostate cancer is not just a man's concern - the use of PSA screening in transgender women.
Nik-Ahd F; Anger JT; Cooperberg MR; Freedland SJ
Nat Rev Urol; 2023 Jun; 20(6):323-324. PubMed ID: 37217694
[No Abstract] [Full Text] [Related]
2. Beyond the PSA test: How to better stratify a patient's risk of prostate cancer.
Lewis R; Hornberger B
JAAPA; 2017 Aug; 30(8):51-54. PubMed ID: 28742748
[TBL] [Abstract][Full Text] [Related]
3. Prostate-Specific Antigen Screening in Transgender Patients.
Nik-Ahd F; Jarjour A; Figueiredo J; Anger JT; Garcia M; Carroll PR; Cooperberg MR; Vidal AC; Freedland SJ
Eur Urol; 2023 Jan; 83(1):48-54. PubMed ID: 36344317
[TBL] [Abstract][Full Text] [Related]
4. Prostate Cancer and the Evolving Role of Biomarkers in Screening and Diagnosis.
Rodriguez JF; Eggener SE
Radiol Clin North Am; 2018 Mar; 56(2):187-196. PubMed ID: 29420975
[TBL] [Abstract][Full Text] [Related]
5. Disparities in Prostate Cancer Screening for Transgender Women: An Analysis of the MarketScan Database.
Premo H; Gordee A; Lee HJ; Scales CD; Moul JW; Peterson A
Urology; 2023 Jun; 176():237-242. PubMed ID: 36972765
[TBL] [Abstract][Full Text] [Related]
6. Sudden PSA rise to ≥20 ng/ml and prostate cancer diagnosis in the United States: A population-based study.
Vilson FL; Li S; Brooks JD; Eisenberg ML
Prostate; 2020 Dec; 80(16):1438-1443. PubMed ID: 32956488
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer in transgender women: what does a urologist need to know?
Bertoncelli Tanaka M; Sahota K; Burn J; Falconer A; Winkler M; Ahmed HU; Rashid TG;
BJU Int; 2022 Jan; 129(1):113-122. PubMed ID: 34157213
[TBL] [Abstract][Full Text] [Related]
8. Impact of recent screening on predicting the outcome of prostate cancer biopsy in men with elevated prostate-specific antigen: data from the European Randomized Study of Prostate Cancer Screening in Gothenburg, Sweden.
Vickers AJ; Cronin AM; Aus G; Pihl CG; Becker C; Pettersson K; Scardino PT; Hugosson J; Lilja H
Cancer; 2010 Jun; 116(11):2612-20. PubMed ID: 20336781
[TBL] [Abstract][Full Text] [Related]
9. Decision making and prostate cancer screening.
Knight SJ
Urol Clin North Am; 2014 May; 41(2):257-66. PubMed ID: 24725488
[TBL] [Abstract][Full Text] [Related]
10. Prostate-specific antigen 1.5-4.0 ng/mL: a diagnostic challenge and danger zone.
Crawford ED; Moul JW; Rove KO; Pettaway CA; Lamerato LE; Hughes A
BJU Int; 2011 Dec; 108(11):1743-9. PubMed ID: 21711431
[TBL] [Abstract][Full Text] [Related]
11. [Screening for prostate cancer using prostate-specific antigen (PSA) : A commentary on a systematic review and meta-analysis].
Borkowetz A
Urologe A; 2019 Aug; 58(8):925-928. PubMed ID: 31240375
[No Abstract] [Full Text] [Related]
12. Interpretation of the prostate-specific antigen history in assessing life-threatening prostate cancer.
Kettermann AE; Ferrucci L; Trock BJ; Metter EJ; Loeb S; Carter HB
BJU Int; 2010 Nov; 106(9):1284-90; discussion 1290-2. PubMed ID: 20477823
[TBL] [Abstract][Full Text] [Related]
13. Re: Reconsidering Prostate Cancer Mortality - The Future of PSA Screening: The future of PSA screening by reconsidering prostate cancer mortality.
Borghesi M; Suardi N; Terrone C
Eur Urol; 2020 Dec; 78(6):929. PubMed ID: 32622550
[No Abstract] [Full Text] [Related]
14. Screening for prostate cancer.
Brawley OW; Ankerst DP; Thompson IM
CA Cancer J Clin; 2009; 59(4):264-73. PubMed ID: 19564245
[TBL] [Abstract][Full Text] [Related]
15. Updated results from the European Randomized Study of Prostate-Specific Antigen (PSA) Screening for Prostate Cancer: are Asian countries encouraged to promote PSA screening?
Sugimoto M; Kakehi Y
Asian J Androl; 2012 Jul; 14(4):522-4. PubMed ID: 22751444
[No Abstract] [Full Text] [Related]
16. Prostate-specific antigen (PSA) as a possible biomarker in non-prostatic cancer: A review.
Pérez-Ibave DC; Burciaga-Flores CH; Elizondo-Riojas MÁ
Cancer Epidemiol; 2018 Jun; 54():48-55. PubMed ID: 29579692
[TBL] [Abstract][Full Text] [Related]
17. Prostate Cancer Screening and the Associated Controversy.
Tabayoyong W; Abouassaly R
Surg Clin North Am; 2015 Oct; 95(5):1023-39. PubMed ID: 26315521
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer: Numeracy and understanding of risk reduction of PSA screening.
Subramanian V; Kattan MW
Nat Rev Urol; 2018 Apr; 15(4):208-209. PubMed ID: 29460924
[No Abstract] [Full Text] [Related]
19. Introduction to a seminar on revisiting the value of PSA-based prostate cancer screening.
Carlsson SV
Urol Oncol; 2023 Feb; 41(2):76-77. PubMed ID: 35523706
[No Abstract] [Full Text] [Related]
20. Screening for Prostate Cancer-Beyond Total PSA, Utilization of Novel Biomarkers.
Morgan T; Palapattu G; Wei J
Curr Urol Rep; 2015 Sep; 16(9):63. PubMed ID: 26169584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
